From AVAC <[email protected]>
Subject New Episode of Px Pulse! CAB-LA is a Highly Effective HIV Prevention Option; Now what?
Date December 17, 2020 2:45 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** CAB-LA is a Highly Effective HIV Prevention Option; Now what?
------------------------------------------------------------
December 17, 2020

Dear Advocates,

A brand-new episode of AVAC’s Px Pulse podcast ([link removed]) is ready for download. Tune in to hear the promise and complexities of long-acting injectable cabotegravir (CAB-LA) ([link removed]) —the latest proven HIV prevention method.

Amidst a year rife with challenges, some of the best news was born out of the HIV prevention research field. This included early results from two trials—HPTN 083 ([link removed]) andHPTN 084 ([link removed]) —showing CAB-LA was safe and highly effective at preventing HIV when compared to daily oral TDF/FTC (Truvada) in men who have sex with men, transgender women and cisgender women. Overall HIV incidence rates in the trials were remarkably low, demonstrating that both oral and injectable PrEP are safe and effective options—an especially important finding for cisgender women, for whom oral PrEP data had been inconsistent.

In this episode of Px Pulse,Raphael Landovitz ([link removed]) andSinead Delany-Moretlwe ([link removed]) , lead investigators of the HPTN 083 and 084 trials, respectively, set the stage with topline research findings and discuss how CAB-LA might fit in with existing HIV prevention options. And with eyes on implementation,Definate Nhamo ([link removed]) , a program manager from Pangaea Zimbabwe AIDS Trust (PZAT), and Jason Reed, a technical advisor withJhpiego ([link removed]) , outline priorities for the work ahead in policy making, programming, advocacy and funding to get CAB-LA programmed as part of a growing array of HIV prevention options.

Check out AVAC’s dedicated webpage on C ([link removed]) AB-LA ([link removed]) for a curated list of research and advocacy resources.

For the full podcast episode, highlights and more resources, visit avac.org/px-pulse ([link removed]) . And subscribe on Apple Podcasts ([link removed]) , Spotify ([link removed]) or wherever you get your podcasts!

Best,
AVAC


Seeking Nominees for the 2021 Omololu Falobi Award
Do you know a courageous and inspiring young activist, advocate or community engagement worker who impressed and inspired you in 2020? Someone who innovated to ensure that research continued safely despite COVID-19? Someone who advocated to ensure that HIV treatment, care and prevention did not stop? Someone who shone a light on human rights violations, or who demanded that community voices help shape the response? Consider nominating them for this award! Submission deadline is January 4. Learn more at www.avac.org/falobi.


============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis